Publication:
IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma

Placeholder

Organizational Units

Program

Authors

GÜLER, Beril
ÇAKIR, FATMA BETÜL
Cay, A.
Mirapoglu, S.
Turkmen, A. Vehaboglu
Aki, H.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Keywords

Citation

ÇAKIR F. B. , GÜLER B., Cay A., Mirapoglu S., Turkmen A. V. , Aki H., -IRF4 Positivity is a Novel Diagnostic and Prognostic Marker for Diffuse Large B Cell Lymphoma-, PEDIATRIC BLOOD & CANCER, cilt.65, 2018

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads


Sustainable Development Goals